Graves眼病患者生活質(zhì)量及眼病特異性生活質(zhì)量的相關(guān)性
發(fā)布時間:2019-03-15 07:04
【摘要】:目的評估Graves眼病(GO)患者的生活質(zhì)量與眼病活動度、甲狀腺自身抗體等的相關(guān)性。方法以SF-36量表及眼病特異性生活質(zhì)量量表(GO-QOL)調(diào)查44例GO患者的生活質(zhì)量評分,檢測患者的甲狀腺功能、相關(guān)抗體水平及疾病活動度評分。結(jié)果年齡45歲的GO患者SF-36評分、GO-QOL評分顯著低于年齡≤45歲的患者(P0.05)。促甲狀腺激素受體抗體(TRAb)10 IU/m L的患者GO-QOL評分及其中的社會心理評分低于TRAb≤10 IU/m L的患者(P0.05)。GO眼病活動度評分≥3分的患者SF-36評分和GO-QOL評分均顯著低于眼病活動度評分3分的患者(均P0.01)。結(jié)論 GO患者眼病特異性的生活質(zhì)量降低,降低程度與年齡、TRAb水平和眼病活動度相關(guān)。
[Abstract]:Objective to evaluate the correlation between the quality of life (QOL) of (GO) patients with Graves ophthalmopathy and the activity of ophthalmopathy, thyroid autoantibodies and so on. Methods SF- 36 and GO-QOL were used to investigate the quality of life (QOL) scores of 44 patients with GO. Thyroid function, related antibody level and disease activity score were measured. Results the SF-36 score and GO-QOL score of 45-year-old patients with GO were significantly lower than those with age 鈮,
本文編號:2440407
[Abstract]:Objective to evaluate the correlation between the quality of life (QOL) of (GO) patients with Graves ophthalmopathy and the activity of ophthalmopathy, thyroid autoantibodies and so on. Methods SF- 36 and GO-QOL were used to investigate the quality of life (QOL) scores of 44 patients with GO. Thyroid function, related antibody level and disease activity score were measured. Results the SF-36 score and GO-QOL score of 45-year-old patients with GO were significantly lower than those with age 鈮,
本文編號:2440407
本文鏈接:http://sikaile.net/yixuelunwen/nfm/2440407.html
最近更新
教材專著